Skip to main content
M. Kelsey Baron
( out of 21 reviews )

M. Kelsey Baron, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-585-2626
  • Dr. Kelsey Baron is an Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies. She specializes in treating patients with various types of lymphoma and chronic lymphocytic leukemia (CLL). Her current research focuses on improving outcomes in patients with lymphoma through novel treatment approaches, advancing clinical trials, evaluating outcomes for patients treated with bispecific antibodies, and expanding access to care for people with HIV associated lymphomas. She completed both her Internal Medicine residency training and Hematology & Oncology fellowship training at the University of Utah/Huntsman Cancer Institute.

    To schedule an appointment New Patients: 801-585-6906 Returning patients: 801-585-2626 or schedule through MyChart.

    For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    4.9 /5
    ( out of 21 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    November 18, 2024
    HUNTSMAN CANCER CENTER

    Dr. Baron is excellent in every respect.

    November 17, 2024
    HUNTSMAN CANCER CENTER

    Doctor Baron is great! My visit with her and her staff went very well.

    November 09, 2024
    HUNTSMAN CANCER CENTER

    Dr Baron was extremely supportive and explained my condition in terms I could easily understand. She was able to answer my questions and explained very well the prognosis of my case and me understand how to handle the other issues I am going through. She was extremely courteous and friendly.

    November 06, 2024
    HUNTSMAN CANCER CENTER

    profoundly competent, cheerful, compassionate and kind, thorough, and professional.

    October 07, 2024
    HUNTSMAN CANCER CENTER

    She was very professional and very knowledgeable . She explained everything in full detail. She made me feel very comfortable with my choice to have her as my oncologist

    October 07, 2024
    HUNTSMAN CANCER CENTER

    Very detailed Exam , with frank comments. Top Draw Doctor,and I have been to a few !

    October 06, 2024
    HUNTSMAN CANCER CENTER

    Doctor Baron is a superb provider who listens, responds with intelligent suggestions and advice and contemplates the implications of patient input and test results. I have to believe that oncology is challenging both intellectually and emotionally and I hope that someone so dedicated and committed to her field can stay the course. We will all benefit.

    September 21, 2024
    HUNTSMAN CANCER CENTER

    Dr Baron explained everything to me thoroughly and carefully; she listened and answered all of my questions. She demonstrated great care and concern throughout my visit. I felt comfortable and confident during my time with her.

    September 21, 2024
    HUNTSMAN CANCER CENTER

    Doctor Baron was very informative about what to expect and explained everything in full detail.

  • Dr. Kelsey Baron is an Assistant Professor of Medicine in the Division of Hematology and Hematologic Malignancies. She specializes in treating patients with various types of lymphoma and chronic lymphocytic leukemia (CLL). Her current research focuses on improving outcomes in patients with lymphoma through novel treatment approaches, advancing clinical trials, evaluating outcomes for patients treated with bispecific antibodies, and expanding access to care for people with HIV associated lymphomas. She completed both her Internal Medicine residency training and Hematology & Oncology fellowship training at the University of Utah/Huntsman Cancer Institute.

    To schedule an appointment New Patients: 801-585-6906 Returning patients: 801-585-2626 or schedule through MyChart.

    For questions regarding our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist (801) 587-4630.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology & Oncology - Huntsman Cancer Institute/University of Utah Spencer Fox Eccles School of Medicine Chief Fellow
    Fellowship Hematology & Oncology - Huntsman Cancer Institute/University of Utah Spencer Fox Eccles School of Medicine Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Professional Medical Medicine - University of Toledo College of Medicine and Life Sciences M.D.
    Undergraduate Advanced Spanish Study Abroad Program - La Universidad de Gran Rosario
    Undergraduate Spanish - Ohio State University, Honors College B.A.
    Undergraduate Biology - Ohio State University, Honors College B.S.

    Selected Publications

    Journal Article

    1. Gociman S, Baron K, Hu B, Zussman J, Madigan LM (2022). Blistering Lesions Associated With Loncastuximab Tesirine. JAMA Dermatol, 158(7), 831-832. (Read full article)
    2. Baron MK, Wang X, Nevala-Plagemann C, Moser JC, Haaland B, Garrido-Laguna I (2021). Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma. Pancreas, 50(6), 796-802. (Read full article)
    3. Baron K, Moser JC, Patel S, Grossmann KF, Colonna SV, Hyngstrom JR (2020). Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies. J Oncol Pharm Pract, 27(3), 555-559. (Read full article)
    4. Carlson SJ, Fleig A, Baron MK, Berg IA, Alber BE (2019). Barriers to 3-Hydroxypropionate-Dependent Growth of Rhodobacter sphaeroides by Distinct Disruptions of the Ethylmalonyl Coenzyme A Pathway. J Bacteriol, 201(4). (Read full article)

    Letter

    1. Baron MK, Osborn JD, Tao R, Lee CJ (2019). Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome. [Letter to the editor]. Leuk Lymphoma, 61(1), 231-233. (Read full article)